Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Amgen to buy Horizon Therapeutics for $26.4B

Por: Fox Business Business December 12, 2022

thumbnail

Graviton Biopharmaceutical Holdings Chairman and CEO Sam Waksal discusses growth investment opportunities in biotech and how the sector should be a national priority. Amgen announced on Monday that it will acquire Horizon Therapeutics in a $26 billion deal, extending the company’s 20-year commercial and medical legacy in inflammation and nephrology. California-based Amgen will pay $116.50 in cash for each share of Horizon, which makes 12... + full article



Similar News

Amgen to buy Horizon Therapeutics in $26.4B deal

Associated Press USA Business December 12, 2022

Amgen is spending more than $26 billion to dive deeper into rare disease treatments with a deal for drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a thyroid eye disease treatment that... + más

Amgen to buy Horizon Therapeutics in $26.4B deal | 10 WBNS

Amgen to buy Horizon Therapeutics in $26.4B deal | ABC News


Billionaire John Paulson Stands To Make $500 Million From Horizon’s Sale To Amgen

Forbes USA Business December 12, 2022

thumbnailHedge fund billionaire John Paulson stands to make a half billion dollars from Horizon's sale to Amgen.Patrick McMullan via Getty Images It’s not , but for hedge fund billionaire John Paulson, it wasn’t so bad either. Paulson’s firm, Paulson & Co., famously made... + más

Amgen to buy Horizon Therapeutics in $26.4B deal | Associated Press

Thorns owner Paulson steps away after damning abuse report | WPLG Local 10


Amgen to buy Horizon Therapeutics in $26.4B deal

ABC News USA Health December 12, 2022

thumbnailAmgen is spending more than $26 billion to dive deeper into rare disease treatments with the acquisition of drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a treatment for thyroid eye... + más

Amgen to buy Horizon Therapeutics in $26.4B deal | Associated Press

Amgen to buy Horizon Therapeutics in $26.4B deal | 10 WBNS


Amgen to buy Horizon Therapeutics in $26.4B deal

10 WBNS USA Health December 12, 2022

thumbnailLOS ANGELES — Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, for about $26.4 billion. Each Horizon shareholder will receive $116.50 per share for each share they own. The deal has an enterprise... + más

Amgen to buy Horizon Therapeutics in $26.4B deal | Associated Press

Amgen to buy Horizon Therapeutics in $26.4B deal | ABC News


Amgen to buy Horizon Therapeutics in $26.4-billion deal

Los Angeles Times USA Science December 12, 2022

thumbnailAmgen is spending more than $26 billion to dive deeper into rare disease treatments with the acquisition of drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a treatment for thyroid eye... + más

Amgen to buy Horizon Therapeutics in $26.4B deal | Associated Press

Amgen to buy Horizon Therapeutics in $26.4B deal | 10 WBNS


Can you buy Nplate, the radiation drug the government is stockpiling?

Newsweek USA Tech October 11, 2022

thumbnailThe Biden administration has placed an order for $290 million worth of a drug that can be used to treat radiation sickness.On October 4, the United States Department for Health and Human Services (HHS) announced it was purchasing a supply of the drug Nplate as part of... + más

The U.S. ordered $290 million supply of a radiation sickness drug. Why there's no cause for alarm. | NBC News

Chernobyl radiation caused frogs to genetically mutate, turning black | Newsweek


Horizon Worlds metaverse app so bad that Meta has to force employees to use it

9to5Mac USA Tech October 07, 2022

thumbnailIt seems is having problems persuading even its own employees to don one of its headsets and use its primary metaverse app, Horizon Worlds. So much so that an internal memo says the company would “hold managers accountable” for their teams using it. It’s one of a set of... + más

Meta’s VR social network Horizon is too buggy and employees are barely using it | The Verge

When metaverse worlds collide in Congress | The Hill



About iurex | Privacy Policy | Disclaimer |